{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T04:24:53Z","timestamp":1789878293854,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T00:00:00Z","timestamp":1599004800000},"content-version":"vor","delay-in-days":2377,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1074\/jbc.m113.514166","type":"journal-article","created":{"date-parts":[[2014,2,11]],"date-time":"2014-02-11T04:03:13Z","timestamp":1392091393000},"page":"9254-9262","source":"Crossref","is-referenced-by-count":18,"title":["Targeting of Receptor for Advanced Glycation End Products Suppresses Cyst Growth in Polycystic Kidney Disease"],"prefix":"10.1016","volume":"289","author":[{"given":"Eun Young","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo Hye","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Ji","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EunSun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Young","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Hoon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M113.514166_bib1","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1083\/jcb.201006173","article-title":"The cell biology of polycystic kidney disease","volume":"191","author":"Chapin","year":"2010","journal-title":"J. Cell Biol."},{"key":"10.1074\/jbc.M113.514166_bib2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1523-1755.2001.00768.x","article-title":"Angiogenesis in autosomal-dominant polycystic kidney disease","volume":"60","author":"Bello-Reuss","year":"2001","journal-title":"Kidney Int."},{"key":"10.1074\/jbc.M113.514166_bib3","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1681\/ASN.2011040340","article-title":"Dose-dependent effects of sirolimus on mTOR signaling and polycystic kidney disease","volume":"23","author":"Novalic","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1074\/jbc.M113.514166_bib4","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/ki.2010.250","article-title":"Sirolimus attenuates disease progression in an orthologous mouse model of human autosomal dominant polycystic kidney disease","volume":"78","author":"Zafar","year":"2010","journal-title":"Kidney Int."},{"key":"10.1074\/jbc.M113.514166_bib5","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1056\/NEJMoa0907419","article-title":"Sirolimus and kidney growth in autosomal dominant polycystic kidney disease","volume":"363","author":"Serra","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1074\/jbc.M113.514166_bib6","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1003491","article-title":"Everolimus in patients with autosomal dominant polycystic kidney disease","volume":"363","author":"Walz","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1074\/jbc.M113.514166_bib7","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature05348","article-title":"Long-lasting arrest of murine polycystic kidney disease with CDK inhibitor roscovitine","volume":"444","author":"Bukanov","year":"2006","journal-title":"Nature."},{"key":"10.1074\/jbc.M113.514166_bib8","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1073\/pnas.1011498108","article-title":"Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis","volume":"108","author":"Takiar","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1074\/jbc.M113.514166_bib9","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nm.2171","article-title":"Inhibition of glucosylceramide accumulation results in effective blockade of polycystic kidney disease in mouse models","volume":"16","author":"Natoli","year":"2010","journal-title":"Nat. Med."},{"key":"10.1074\/jbc.M113.514166_bib10","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1242\/dev.049437","article-title":"Polycystin-dependent fluid flow sensing targets histone deacetylase 5 to prevent the development of renal cysts","volume":"137","author":"Xia","year":"2010","journal-title":"Development."},{"key":"10.1074\/jbc.M113.514166_bib11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000315859","article-title":"Effects of specific genes activating RAGE on polycystic kidney disease","volume":"32","author":"Park","year":"2010","journal-title":"Am. J. Nephrol."},{"key":"10.1074\/jbc.M113.514166_bib12","doi-asserted-by":"crossref","first-page":"F645","DOI":"10.1152\/ajprenal.00398.2004","article-title":"Advanced glycation end products and the kidney","volume":"289","author":"Bohlender","year":"2005","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1074\/jbc.M113.514166_bib13","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1007\/s00109-005-0688-7","article-title":"Understanding RAGE, the receptor for advanced glycation end products","volume":"83","author":"Bierhaus","year":"2005","journal-title":"J. Mol. Med."},{"key":"10.1074\/jbc.M113.514166_bib14","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1365-2362.2010.02317.x","article-title":"Advanced glycation end-products and the kidney","volume":"40","author":"Busch","year":"2010","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1074\/jbc.M113.514166_bib15","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1074\/jbc.M310124200","article-title":"S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE)","volume":"279","author":"Arumugam","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1074\/jbc.M113.514166_bib16","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1600-0625.2011.01408.x","article-title":"Involvement of RAGE, MAPK, and NF-\u03baB pathways in AGEs-induced MMP-9 activation in HaCaT keratinocytes","volume":"21","author":"Zhu","year":"2012","journal-title":"Exp. Dermatol."},{"key":"10.1074\/jbc.M113.514166_bib17","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1172\/JCI117926","article-title":"Prevention of diabetic nephropathy in db\/db mice with glycated albumin antagonists: a novel treatment strategy","volume":"95","author":"Cohen","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1074\/jbc.M113.514166_bib18","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1681\/ASN.V12102098","article-title":"Aminoguanidine ameliorates overexpression of prosclerotic growth factors and collagen deposition in experimental diabetic nephropathy","volume":"12","author":"Kelly","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1074\/jbc.M113.514166_bib19","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/35012626","article-title":"Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases","volume":"405","author":"Taguchi","year":"2000","journal-title":"Nature."},{"key":"10.1074\/jbc.M113.514166_bib20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2796.2006.01743.x","article-title":"Polycystic kidney disease: genes, proteins, animal models, disease mechanisms and therapeutic opportunities","volume":"261","author":"Torres","year":"2007","journal-title":"J. Intern. Med."},{"key":"10.1074\/jbc.M113.514166_bib21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0092-8674(00)81570-6","article-title":"Somatic inactivation of Pkd2 results in polycystic kidney disease","volume":"93","author":"Wu","year":"1998","journal-title":"Cell"},{"key":"10.1074\/jbc.M113.514166_bib22","doi-asserted-by":"crossref","first-page":"7214","DOI":"10.1074\/jbc.M805890200","article-title":"Cyst formation in kidney via B-Raf signaling in the PKD2 transgenic mice","volume":"284","author":"Park","year":"2009","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.514166_bib23","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1046\/j.1523-1755.2001.00065.x","article-title":"Increased renal expression of monocyte chemoattractant protein-1 and osteopontin in ADPKD in rats","volume":"60","author":"Cowley","year":"2001","journal-title":"Kidney Int."},{"key":"10.1074\/jbc.M113.514166_bib24","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/ki.2008.395","article-title":"Neutrophil gelatinase-associated lipocalin suppresses cyst growth by Pkd1 null cells in vitro and in vivo","volume":"74","author":"Wei","year":"2008","journal-title":"Kidney Int"},{"key":"10.1074\/jbc.M113.514166_bib25","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1128\/jvi.71.3.1842-1849.1997","article-title":"Construction of adenovirus vectors through Cre-lox recombination","volume":"71","author":"Hardy","year":"1997","journal-title":"J. Virol."},{"key":"10.1074\/jbc.M113.514166_bib26","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/hmg\/ddn039","article-title":"Cyst formation and activation of the extracellular regulated kinase pathway after kidney specific inactivation of Pkd1","volume":"17","author":"Shibazaki","year":"2008","journal-title":"Hum. Mol. Genet"},{"key":"10.1074\/jbc.M113.514166_bib27","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/ng1097-179","article-title":"Perinatal lethality with kidney and pancreas defects in mice with a targeted Pkd1 mutation","volume":"17","author":"Lu","year":"1997","journal-title":"Nat. Genet"},{"key":"10.1074\/jbc.M113.514166_bib28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0014-5793(03)00846-9","article-title":"The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking site","volume":"550","author":"Ishihara","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1074\/jbc.M113.514166_bib29","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nri1594","article-title":"High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal","volume":"5","author":"Lotze","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1074\/jbc.M113.514166_bib30","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1681\/ASN.2009010018","article-title":"Advanced glycation end products induce tubular CTGF via TGF-\u03b2-independent Smad3 signaling","volume":"21","author":"Chung","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1074\/jbc.M113.514166_bib31","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/ncpneph0070","article-title":"Mechanisms of disease: autosomal dominant and recessive polycystic kidney diseases","volume":"2","author":"Torres","year":"2006","journal-title":"Nat. Clin. Pract. Nephrol."},{"key":"10.1074\/jbc.M113.514166_bib32","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1681\/ASN.2004090800","article-title":"Extracellular signal-regulated kinase inhibition slows disease progression in mice with polycystic kidney disease","volume":"17","author":"Omori","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1074\/jbc.M113.514166_bib33","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1478-811X-7-12","article-title":"The receptor RAGE: bridging inflammation and cancer","volume":"7","author":"Riehl","year":"2009","journal-title":"Cell Commun. Signal."},{"key":"10.1074\/jbc.M113.514166_bib34","first-page":"529","article-title":"Autosomal dominant polycystic kidney disease coexisting with cystic fibrosis","volume":"19","author":"Xu","year":"2006","journal-title":"J. Nephrol."},{"key":"10.1074\/jbc.M113.514166_bib35","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nm1783","article-title":"A tumor necrosis factor-\u03b1-mediated pathway promoting autosomal dominant polycystic kidney disease","volume":"14","author":"Li","year":"2008","journal-title":"Nat. Med."},{"key":"10.1074\/jbc.M113.514166_bib36","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1681\/ASN.2007101109","article-title":"RAGE mediates podocyte injury in adriamycin-induced glomerulosclerosis","volume":"19","author":"Guo","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1074\/jbc.M113.514166_bib37","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.tem.2009.07.003","article-title":"RAGE, glomerulosclerosis and proteinuria: roles in podocytes and endothelial cells","volume":"21","author":"D'Agati","year":"2010","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1074\/jbc.M113.514166_bib38","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00467-011-1988-5","article-title":"The possible role of esRAGE and sRAGE in the natural history of diabetic nephropathy in childhood","volume":"27","author":"Giannini","year":"2012","journal-title":"Pediatr. Nephrol."},{"key":"10.1074\/jbc.M113.514166_bib39","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1681\/ASN.2005010062","article-title":"Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy","volume":"16","author":"Forbes","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1074\/jbc.M113.514166_bib40","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1007\/s00125-010-1837-2","article-title":"Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptor","volume":"53","author":"Sourris","year":"2010","journal-title":"Diabetologia."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820419957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820419957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M113.514166","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T11:41:14Z","timestamp":1641296474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820419957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":40,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0021925820419957"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m113.514166","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}